60-Day Peripheral Nerve Stimulation Provides Durable Relief from Occipital Head Pain: 12-Month Outcomes from a Prospective Study

Friday, November 14, 2025

8:00 AM - 8:08 AM CT

Location: 301 - 302

Introduction:

Sixty-day peripheral nerve stimulation (PNS) treatment has shown positive results for the treatment of various chronic pain conditions, including in the present study where participants with cervicogenic headache (CGH) or occipital neuralgia underwent 60-days of stimulation of the occipital nerves.¹ This study aimed to assess the durability of relief from pain and pain interference in participants with CGH or ON, with follow-up outcomes presented here up to 12 months after starting 60-day PNS.

Presenting Author(s)

Narayan Kissoon, MD

Chair, Division of Headache, Department of Neurology
Mayo Clinic, United States

Co-Author(s)

CG

Christopher A. Gilmore, MD

President
Carolinas Pain Institute, United States
ZM

Zachary L. McCormick, MD

Vice Chair and Associate Professor in the Department of Physical Medicine and Rehabilitation (PM&R)
University of Utah Health, United States
GG

Genaro Gutierrez, MD

Medical Director
Ambulatory Surgical Center of Austin, United States
ME

Mitchell P. Engle, MD, PhD

Pain Medicine Specialist
Institute of Precision Pain Medicine, United States
MP

Matthew Pingree, MD

Professor
Mayo Clinic
Rochester, Minnesota, United States
JP

Jason Pope, MD

Pain Medicine Specialist
Evolve Restorative Care, United States
DD

David DiBenedetto, MD

Medical Director
MedVadis Research, United States

Submitting Author(s)

WH

William J. Huffman, PhD

Research Engineer
SPR
Cleveland, Ohio, United States

Co-Author(s)

NC

Nathan Crosby, PhD

Senior Manager, Research and Development
SPR, United States
JB

Joshua Boggs, PhD

Chief Scientific Officer
SPR, United States